Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer

Author(s): Dongwu Liu, Xiaoqian Wang, Zhiwei Chen

Journal Name: Current Pharmaceutical Biotechnology

Volume 17 , Issue 6 , 2016

Become EABM
Become Reviewer


The cell-mediated immunity and cytotoxic agents play a significant role on tumor cell apoptosis. Tumor necrosis factor-α (TNF-α) is an intricate linker between inflammation and cancer through mediating the process of apoptosis and cell-mediated immunity. A variety of evidences have confirmed the critical role of TNF-α on tumor migration, proliferation, matrix degradation, tumor metastasis, invasion, and angiogenesis. Through binding to receptors, TNF-α participates in activating multiple cell signaling cascades that link inflammation, survival and evolution towards breast cancer. TNF-α is an important agent for tumor biotherapy, but its clinical application is limited for its severe fatal systemic toxicity. The poly-lactic acid microspheres (PLAM) with intratumoral cytokine release hold tremendous potential for the immunotherapy of breast cancer, and TNF-α antagonists may offer therapeutic potential in solid tumors. In addition, TNF-α is related with the blockage of estrogen and progesterone receptors. For breast cancer treatment, it is necessary to understand the molecular signaling pathways that mediate TNF-α and the aggressive behavior of negative breast cancer. The aim of present review is to summarize the effect of TNF-α on breast cancer cells.

Keywords: TNF-α, breast cancer, signal pathway, tumor biotherapy, estrogen, tumor proliferation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 11 April, 2016
Page: [486 - 494]
Pages: 9
DOI: 10.2174/1389201017666160301102713
Price: $65

Article Metrics

PDF: 65